Jonathan Gillis, Chief Scientific Officer at MapLight Therapeutics, Inc. (MPLT), sold 11,513 shares at $8.08 ($93K) on 2026-10-15, disclosed to the SEC on 2026-10-16.
Open-market sale of $93k MPLT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |